Main public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 21:15, 31 January 2024 Edzelco talk contribs created page File:Clinical Studies 1.png
- 21:15, 31 January 2024 Edzelco talk contribs uploaded File:Clinical Studies 1.png
- 21:07, 31 January 2024 Edzelco talk contribs created page File:Effects of hepatic impairment and renal impairment on daridorexant PK.png
- 21:07, 31 January 2024 Edzelco talk contribs uploaded File:Effects of hepatic impairment and renal impairment on daridorexant PK.png
- 21:07, 31 January 2024 Edzelco talk contribs created page File:Effect of daridorexant on the PK of other compounds.png
- 21:07, 31 January 2024 Edzelco talk contribs uploaded File:Effect of daridorexant on the PK of other compounds.png
- 21:06, 31 January 2024 Edzelco talk contribs created page File:Effect of co-administered compounds on the PK of daridorexant.png
- 21:06, 31 January 2024 Edzelco talk contribs uploaded File:Effect of co-administered compounds on the PK of daridorexant.png
- 21:01, 31 January 2024 Edzelco talk contribs created page File:Packaging 3.png
- 21:01, 31 January 2024 Edzelco talk contribs uploaded File:Packaging 3.png
- 21:01, 31 January 2024 Edzelco talk contribs created page File:Packaging 2.png
- 21:01, 31 January 2024 Edzelco talk contribs uploaded File:Packaging 2.png
- 21:00, 31 January 2024 Edzelco talk contribs created page File:Packaging 1.png
- 21:00, 31 January 2024 Edzelco talk contribs uploaded File:Packaging 1.png
- 20:49, 31 January 2024 Edzelco talk contribs created page File:Daridorexant.png
- 20:49, 31 January 2024 Edzelco talk contribs uploaded File:Daridorexant.png
- 00:25, 25 January 2024 Edzelco talk contribs created page Orbifloxacin (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Orbifloxacin |aOrAn=a |drugClass=fluoroquinolone carboxylic acid derivatives |indicationType=treatment |indication=urinary tract infections (cystitis) in dogs caused by susceptible strains of <i>Staphylococcus pseudintermedius, Proteus mirabilis, Escherichia coli</i> and <i>Enterococcus faecalis</i>. |adverseReactions=In a field study, when the tablet formulation of orbifloxacin...")
- 00:16, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin packaging.png
- 00:16, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin packaging.png
- 00:15, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin suspension 2.png
- 00:15, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin suspension 2.png
- 00:15, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin suspension.png
- 00:15, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin suspension.png
- 00:15, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin structure.png
- 00:15, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin structure.png
- 14:28, 23 January 2024 Edzelco talk contribs created page Ado-Trastuzumab Emtansine (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Ado-trastuzumab emtansine |aOrAn=a |drugClass=HER2-targeted antibody and microtubule inhibitor conjugate |indicationType=treatment |indication=1.) patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either: a.) Received prior therapy for metastatic disease, or b.) Developed disease recurrence during or wi...")
- 14:24, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine packaging 160mg.png
- 14:24, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine packaging 160mg.png
- 14:22, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine packaging.png
- 14:22, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine packaging.png
- 14:19, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine supply.png
- 14:19, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine supply.png
- 14:19, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine structure.png
- 14:19, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine structure.png
- 23:32, 22 January 2024 Edzelco talk contribs created page Omacetaxine mepesuccinate (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Omacetaxine mepesuccinate (SYNRIBO) |aOrAn=an |drugClass=injection |indicationType=treatment |indication=adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI) |fdaLIADAdult=*Induction Dose: 1.25 mg/m2 administered by subcutaneous injection twice daily for 14 consecutive days of a 28-day cycle. *Maint...")
- 23:08, 22 January 2024 Edzelco talk contribs created page Adipiodone (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Adipiodone meglumine |aOrAn=a |drugClass=a tri-iodinated benzoate derivative and an ionic dimeric contrast agent |indicationType=procedure |indication=diagnostic imaging, as this agent blocks x-ray and appears opaque on x-ray film; thereby it enhances the visibility of the bile ducts and gallbladder during cholangiography and cholecystography procedures |adverseReactions=epilepsy, abdominal pain, and tremor...")
- 21:17, 22 January 2024 Edzelco talk contribs created page File:Adipiodine FDA-Approved Drugs.png
- 21:17, 22 January 2024 Edzelco talk contribs uploaded File:Adipiodine FDA-Approved Drugs.png
- 21:12, 22 January 2024 Edzelco talk contribs created page File:Structure of Adipiodine.png
- 21:12, 22 January 2024 Edzelco talk contribs uploaded File:Structure of Adipiodine.png
- 16:42, 22 January 2024 Edzelco talk contribs created page File:Oclatinib.png
- 16:42, 22 January 2024 Edzelco talk contribs uploaded File:Oclatinib.png
- 16:37, 22 January 2024 Edzelco talk contribs created page Oclacitinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |aOrAn=an |drugClass=immunomodulator |indicationType=treatment |indication=pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age |blackBoxWarningBody=This product is not for human use. Keep this and all drugs out of reach of children. For use in dogs only. Wash hands immediately after handling the tablets. In case of accidental eye contact, flush immediately with...")
- 16:34, 22 January 2024 Edzelco talk contribs created page File:APOQUEL tablets 16 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs uploaded File:APOQUEL tablets 16 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs created page File:APOQUEL tablets 5.4 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs uploaded File:APOQUEL tablets 5.4 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs created page File:APOQUEL tablets 3.6 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs uploaded File:APOQUEL tablets 3.6 mg Tablet Bottle Label.png
- 15:49, 22 January 2024 Edzelco talk contribs created page Absorbable gelatin sponge (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Gelatin Sponge, Absorbable |aOrAn=a |drugClass=sterile, gelatin-base surgical sponge |indicationType=treatment |indication=bleeding as an adjunct to hemostasis when conventional procedure is ineffective. |brandNames=*Gelfoam |lookAlike=*Gelaspon *SurgiFoam }}")
